Mature or peripheral T-cell lymphomas are uncommon, accounting for onl
y 10%-15% of all non-Hodgkin's lymphomas. The classification of these
neoplasms has been controversial. In contrast to B-cell lymphomas, cyt
ologic grade has not been very useful in predicting the clinical cours
e. This finding may result from the generally aggressive clinical cour
se associated with T-cell lymphomas. Prior studies have suggested that
stage of disease may be more important than cytologic subtype. Clinic
al presentation is very important in the classification of T-cell mali
gnancies. For T-cell lymphomas, cytologic features alone are not suffi
cient to distinguish among disease entities. For example, adult T-cell
leukemia/lymphoma (ATLL) often cannot be distinguished morphologicall
y from HTLV-l-negative T-cell lymphomas. Most extranodal T-cell lympho
mas appear to be derived from cytotoxic T cells, which express perfori
n, TIA-1, and granzyme B. Three broad groups of T-cell malignancies ca
n be identified: (1) leukemic or systemic disease; (2) nodal disease;
(3) extranodal disease. Anaplastic large-cell lymphoma (ALCL) is proba
bly the single most common subtype of T-cell lymphoma. Classical ALCL
should be distinguished from primary cutaneous ALCL (CD30+ lymphoproli
ferative disease of the shin), which is a distinct disease entity.